Overlap of acute, subacute, and chronic cutaneous lupus in the same patient

Authors

  • Rosario Collado Gómez Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina
  • Ludmila Rodríguez Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina
  • Camila Bo Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina
  • Esteban Maronna Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina
  • Viviana Alicia Leiro Francisco Javier Muñiz Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v31i1.2526

Keywords:

chronic cutaneous lupus, acute cutaneous lupus, subacute cutaneous lupus, systemic lupus erythematosus

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with multiorgan involvement and variable progression. The skin is one of the most affected organs and, on occasion, it is often crucial in diagnosing the disease. Depending on clinical presentation, evolution, immunological findings, and histopathological features, it is classified into chronic cutaneous lupus erythematosus (CCLE), subacute (SCLE), and acute (ACLE). Herein, we present a patient who developed all three clinical manifestations simultaneously.

Author Biographies

  • Rosario Collado Gómez, Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina

    Resident Physician, Dermatology Unit

  • Ludmila Rodríguez, Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina

    Staff Physician, Dermatology Unit

  • Camila Bo, Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina

    Resident Physician, Dermatology Unit

  • Esteban Maronna, Francisco Javier Muñiz Hospital, City of Buenos Aires, Argentina

    Staff Physician, Pathological Anatomy Unit

  • Viviana Alicia Leiro, Francisco Javier Muñiz Hospital, Autonomous City of Buenos Aires, Argentina

    Head of the Dermatology Unit

References

I. Zambernardi A, Bendjuia G, Manzano R, Berben MD. Lupus eritematoso cutáneo. Estudio de 92 pacientes. Dermatol Argent. 2018;24:41-46.

II. Grönhagen CM, Nyberg F. Cutaneous lupus erythematosus: an update. Indian Dermatol Online J. 2014;5:7-13.

III. Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus. A review for the rheumatologist. J Rheumatol. 2023;50:27-35.

IV. Uva L, Miguel D, Pinheiro C, Freitas JP, et ál. Cutaneous manifestations of systemic lupus erythematosus. Autoimmune Dis. 2012;2012:834291.

V. Watanabe T, Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology. 1995;190:277-283.

VI. Narváez J. Systemic lupus erythematosus 2020. Med Clin Barc. 2020;155:494-501.

VII. Marmor MF, Kellner U, Lai TY, Melles RB, et ál; American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386-1394.

VIII. Prow G, Dan J, Merola JF, Werth VP. Emerging therapies in cutaneous lupus erythematosus. Front Med (Lausanne). 2022;9:968323.

Downloads

Published

2025-04-04

Issue

Vol. 31 No. 1 (2025): January-April

Section

Clinical Cases

License

Copyright (c) 2025 on behalf of the authors. Reproduction rights: Argentine Society of Dermatology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor